194 related articles for article (PubMed ID: 8321830)
1. Passive transepithelial absorption of thyrotropin-releasing hormone (TRH) via a paracellular route in cultured intestinal and renal epithelial cell lines.
Thwaites DT; Hirst BH; Simmons NL
Pharm Res; 1993 May; 10(5):674-81. PubMed ID: 8321830
[TBL] [Abstract][Full Text] [Related]
2. Thyrotropin-releasing hormone (TRH) uptake in intestinal brush-border membrane vesicles: comparison with proton-coupled dipeptide and Na(+)-coupled glucose transport.
Thwaites DT; Simmons NL; Hirst BH
Pharm Res; 1993 May; 10(5):667-73. PubMed ID: 8391693
[TBL] [Abstract][Full Text] [Related]
3. Evidence for predominantly paracellular transport of thyrotropin-releasing hormone across CACO-2 cell monolayers.
Gan LS; Niederer T; Eads C; Thakker D
Biochem Biophys Res Commun; 1993 Dec; 197(2):771-7. PubMed ID: 8267614
[TBL] [Abstract][Full Text] [Related]
4. Studies on the transport of thyrotropin-releasing hormone (TRH) analogues in Caco-2 cell monolayers.
Urayama A; Yamada S; Deguchi Y; Ohmori Y; Kimura R
J Pharm Pharmacol; 2003 May; 55(5):603-8. PubMed ID: 12831502
[TBL] [Abstract][Full Text] [Related]
5. Transepithelial transport and metabolism of thyrotropin-releasing hormone (TRH) in monolayers of a human intestinal cell line (Caco-2): evidence for an active transport component?
Walter E; Kissel T
Pharm Res; 1994 Nov; 11(11):1575-80. PubMed ID: 7870674
[TBL] [Abstract][Full Text] [Related]
6. Transport of thyrotropin-releasing hormone across rat alveolar epithelial cell monolayers.
Morimoto K; Yamahara H; Lee VH; Kim KJ
Life Sci; 1994; 54(26):2083-92. PubMed ID: 8208065
[TBL] [Abstract][Full Text] [Related]
7. The absorptive flux of the anti-epileptic drug substance vigabatrin is carrier-mediated across Caco-2 cell monolayers.
Nøhr MK; Hansen SH; Brodin B; Holm R; Nielsen CU
Eur J Pharm Sci; 2014 Jan; 51():1-10. PubMed ID: 24008184
[TBL] [Abstract][Full Text] [Related]
8. Caco-2 versus Caco-2/HT29-MTX co-cultured cell lines: permeabilities via diffusion, inside- and outside-directed carrier-mediated transport.
Hilgendorf C; Spahn-Langguth H; Regårdh CG; Lipka E; Amidon GL; Langguth P
J Pharm Sci; 2000 Jan; 89(1):63-75. PubMed ID: 10664539
[TBL] [Abstract][Full Text] [Related]
9. Intestinal absorption mechanisms of thyrotropin-releasing hormone.
Yokohama S; Yoshioka T; Yamashita K; Kitamori N
J Pharmacobiodyn; 1984 Jul; 7(7):445-51. PubMed ID: 6436461
[TBL] [Abstract][Full Text] [Related]
10. Effects of peptide structure on transport properties of seven thyrotropin releasing hormone (TRH) analogues in a human intestinal cell line (Caco-2).
Werner U; Kissel T; Stüber W
Pharm Res; 1997 Feb; 14(2):246-50. PubMed ID: 9090718
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the Caco-2 monolayer as a model epithelium for iontophoretic transport.
Leonard M; Creed E; Brayden D; Baird AW
Pharm Res; 2000 Oct; 17(10):1181-8. PubMed ID: 11145222
[TBL] [Abstract][Full Text] [Related]
12. Absence of a transcellular oxalate transport mechanism in LLC-PK1 and MDCK cells cultured on porous supports.
Verkoelen CF; Romijn JC; de Bruijn WC; Boevé ER; Cao LC; Schröder FH
Scanning Microsc; 1993 Sep; 7(3):1031-8; discussion 1038-40. PubMed ID: 8146604
[TBL] [Abstract][Full Text] [Related]
13. H(+)-coupled dipeptide (glycylsarcosine) transport across apical and basal borders of human intestinal Caco-2 cell monolayers display distinctive characteristics.
Thwaites DT; Brown CD; Hirst BH; Simmons NL
Biochim Biophys Acta; 1993 Sep; 1151(2):237-45. PubMed ID: 8373798
[TBL] [Abstract][Full Text] [Related]
14. Paracellular calcium transport across Caco-2 and HT29 cell monolayers.
Blais A; Aymard P; Lacour B
Pflugers Arch; 1997 Jul; 434(3):300-5. PubMed ID: 9178630
[TBL] [Abstract][Full Text] [Related]
15. [Molecular and cell biological analyses for intestinal absorption and renal excretion of drugs].
Saito H
Yakugaku Zasshi; 1997 Aug; 117(8):522-41. PubMed ID: 9306727
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin-converting enzyme (ACE) inhibitor transport in human intestinal epithelial (Caco-2) cells.
Thwaites DT; Cavet M; Hirst BH; Simmons NL
Br J Pharmacol; 1995 Mar; 114(5):981-6. PubMed ID: 7780654
[TBL] [Abstract][Full Text] [Related]
17. Improvement of intestinal absorption of thyrotropin-releasing hormone by chemical modification with lauric acid.
Yamada K; Murakami M; Yamamoto A; Takada K; Muranishi S
J Pharm Pharmacol; 1992 Sep; 44(9):717-21. PubMed ID: 1360521
[TBL] [Abstract][Full Text] [Related]
18. Intestinal absorption of miltefosine: contribution of passive paracellular transport.
Ménez C; Buyse M; Dugave C; Farinotti R; Barratt G
Pharm Res; 2007 Mar; 24(3):546-54. PubMed ID: 17252190
[TBL] [Abstract][Full Text] [Related]
19. Substrate specificity of the di/tripeptide transporter in human intestinal epithelia (Caco-2): identification of substrates that undergo H(+)-coupled absorption.
Thwaites DT; Hirst BH; Simmons NL
Br J Pharmacol; 1994 Nov; 113(3):1050-6. PubMed ID: 7858848
[TBL] [Abstract][Full Text] [Related]
20. Epithelial cells in culture as a model for the intestinal transport of antimicrobial agents.
Ranaldi G; Islam K; Sambuy Y
Antimicrob Agents Chemother; 1992 Jul; 36(7):1374-81. PubMed ID: 1510430
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
